Shanghai, China · Founded 2021 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to focus on the discovery, development, and commercialization of novel targeted radiopharmaceuticals to address significant unmet… Biovision Biomedical Technology is based in Shanghai, China and was founded in 2021. It has raised $42.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$42.3M
Last round
—
Cap table — not yet on record
Biovision Biomedical Technology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Biovision Biomedical Technology with a free account
·Watch Biovision Biomedical Technology: the Monday email on marks, rounds and moves
